Study Performance: Achieving 172% of Enrollment Targets for a Type 1 Diabetes Trial at 3 Sites

Overview

Tekton Research delivered exceptional results in a recent Type 1 Diabetes clinical trial by leveraging its multi-site endocrinology expertise, operational efficiency, and proven site management processes. All three Tekton sites exceeded enrollment targets, contributing to the study’s success.

Best Practices from a Top Site

At our McKinney, TX site, we more than doubled the sponsor’s enrollment goal—enrolling 13 participants against a target of 6. This exceptional achievement prompted the sponsor to visit our site personally to meet with Dr. Aziz and our team to understand what set us apart and how our approach could be shared as a best practice with other sites.

Key Metrics

%
Average enrollment across 3 sites
Goal: 18 | Enrolled: >30
days
Average regulatory turnaround time across 3 sites
days
Average time from activation to first patient visit across 3 sites

Notably, our McKinney, TX site achieved this milestone in just 4 business days, demonstrating our ability to mobilize quickly and efficiently

Solutions

Targeted Patient Recruitment

The key to our success for this study was a disciplined, physician-led strategy. At our McKinney, TX site, Dr. Aziz personally reviewed the list of potential patients, ensuring outreach was limited to individuals with a strong record of compliance and reliability within his practice. Our team conducted thorough pre-screening discussions to ensure fit and interest, and we invested significant time in detailed informed consent conversations. These extra steps helped us enroll patients who not only qualified but fully understood the time commitment and study requirements—leading to higher retention and fewer early withdrawals.

Beyond the robust practice databases at our embedded endocrinology research sites, Tekton's dedicated Patient Recruitment Center in Austin, TX maintains a robust database of trial-ready individuals and stays in touch through regular outreach via email, phone calls, and text messages. By pre-identifying potential participants year-round and engaging with diverse communities through local events and initiatives, we ensure rapid enrollment and strong retention when it’s time to launch.

Accelerated Study Start-Up & Activation

Tekton’s centralized services team leverages a streamlined, proven approach to ensure sites are up and running quickly. With a single point of contact for all site communications, centralized regulatory and IRB coordination, and unified budgeting and contracting processes, sponsors benefit from a fast, predictable, and efficient start-up. Real-time operational dashboards and accurate centralized invoicing keep everything on track and transparent from day one.

Conclusion

This study reflects Tekton’s ability to deliver above-target enrollment, manage accelerated study startup, and operate across multiple specialized sites with consistency and speed. Our strong relationships with PIs and site staff, combined with disciplined processes, make us a trusted partner for high-performance endocrinology research.

Tekton Sites

clinical research neurology studies

Partner With Us

Join the leading sponsors and CROs who trust Tekton Research with their most important clinical trials. Contact us today to discuss how our specialized expertise can help bring your next breakthrough treatment to patients in need.